Why so many companies have stopped trying to create new antibiotics

Editor’s note: Last night on the PBS NewsHour, science correspondent Miles O’Brien kicked off NewsHour’s special, and especially scary, series on the advent of antibiotic-resistant bacteria. This evening, in part two of the series, economics correspondent Paul Solman explores the economic impediments to creating new drugs.

One of the researchers Paul spoke with for the series is John Rex, a former executive at AstraZeneca Pharmaceuticals, in charge of developing new antibiotics. Dr.

What feeling does this article give you?

#hashtags to follow:

PBS NewsHour [+]    Miles [+]    Brien [+]    NewsHour [+]    Paul Solman [+]    Paul [+]    John Rex [+]    AstraZeneca Pharmaceuticals [+]   

More #news: